| dc.contributor.author |
de Silva, H.A. |
en_US |
| dc.contributor.author |
Hewavisenthi, J. |
en_US |
| dc.contributor.author |
Wijesiriwardena, B. |
en_US |
| dc.contributor.author |
Fonseka, M.M.D. |
en_US |
| dc.date.accessioned |
2014-10-29T09:18:22Z |
|
| dc.date.available |
2014-10-29T09:18:22Z |
|
| dc.date.issued |
1999 |
en_US |
| dc.identifier.citation |
The Ceylon Medical Journal. 1999; 44(4): pp.188-189 |
en_US |
| dc.identifier.issn |
0009-0875 (Print) |
en_US |
| dc.identifier.uri |
http://repository.kln.ac.lk/handle/123456789/1403 |
|
| dc.description.abstract |
No Abstract Available |
|
| dc.publisher |
Sri Lanka Medical Association |
en_US |
| dc.subject |
Methyldopa |
en_US |
| dc.subject |
Hypertension-drug therapy |
|
| dc.subject |
Methyldopa-adverse effects |
|
| dc.subject |
Methyldopa-contraindications |
|
| dc.subject |
Antihypertensive Agents |
|
| dc.subject |
Antihypertensive Agents-adverse effects |
|
| dc.title |
Methyldopa use should be restricted |
en_US |
| dc.type |
Letter |
en_US |
| dc.identifier.department |
Pharmacology |
en_US |
| dc.identifier.department |
Pathology |
en_US |
| dc.creator.corporateauthor |
Sri Lanka Medical Association |
en_US |